Autoimmune diseases of the liver, autoimmune hepatitis and primary biliary cirrhosis: Unfinished business

Hepatology Research

Volumn 37, Issue SUPPL. 3, 2007, Pages

  Mackay, Ian R ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

Anti mitochondriala ntibody; Autoimmune hepatitis; Autoimmunity; F actin antibody; Primary biliary cirrhosis; Smooth muscle antibody

Indexed keywords

AUTOANTIBODY; AUTOANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; CYTOCHROME P450; F ACTIN; HLA ANTIGEN; SMOOTH MUSCLE ANTIBODY; TRANSFORMING GROWTH FACTOR BETA; XENOBIOTIC AGENT;

AUTOIMMUNE HEPATITIS; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONFERENCE PAPER; DISEASE MODEL; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL FACTOR; GENETIC PREDISPOSITION; GENETIC SUSCEPTIBILITY; HELPER CELL; HUMAN; IMMUNOASSAY; IMMUNOLOGICAL TOLERANCE; IN VITRO STUDY; INFECTION; LYMPHOCYTE FUNCTION; MEDICAL ASSESSMENT; MEMORY T LYMPHOCYTE; NONHUMAN; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; PROTEIN FUNCTION; REGULATORY T LYMPHOCYTE; SEX DIFFERENCE; STANDARDIZATION; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION; TH1 CELL; TH17 CELL; TH2 CELL;

EID: 35348819908     PISSN: 13866346     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1872-034X.2007.00230.x     Document Type: Conference Paper

References (31)

1. Mackay IR, Czaja AJ, McFarlane IG, Manns MP. Chronic hepatitis. In: Rose NR, Mackay IR, eds. The Autoimmune Diseases, 4th edn. London: Elsevier, 2006; 729-47.
2. Homberg J-C, Abuaf N, Bernard O et al. Chronic active hepatitis with anti-liver/kidney microsome antibody Type 1: A second type of autoimmune hepatitis. Hepatology 1987; 7: 1333-9.
3. Manns MP, Vogel A. Autoimmune hepatitis, from mechanisms to therapy. Hepatology 2006; 43 (2 Suppl 1): S132-44.
4. Ma Y, Bogdanos P, Hussein MJ et al. Clonal T-cell responses to cytochrome P450 IID6 are associated with disease activity in autoimmune hepatitis type 2. Gastroenterology 2006; 130: 868-82.
5. Lapierre P, Djilali-Saiah I, Votozzi S, Alvarez F. A murine model of type 2 autoimmune hepatitis: Xenoimmunization with human antigens. Hepatology 2004; 39: 1066-74.
6. Johnson G, Holborow EJ, Glynn LE. Antibody to smooth muscle in patients with liver disease. Lancet 1965; 2: 878-9.
7. Whittingham S, Irwin J, Mackay IR, Smalley M. Smooth muscle antibody in "autoimmune" hepatitis. Gastroenterology 1966; 51: 495-505.
8. Whittingham S, Mackay IR, Irwin J. Autoimmune hepatitis. Immunofluorescence reactions with cytoplasm of smooth muscle and renal glomerular cells. Lancet 1966; 1: 1333-5.
9. Gabbiani G, Ryan GB, Lamelin JP et al. Human smooth muscle antibody, its identification as anti-actin antibody, and a study of its binding to "non-muscular" cells. Am J Pathol 1973; 72: 473-84.
10. Bottazzo GF, Florin-Christensen A, Fairfax AC. Classification of smooth muscle autoantibodies detected by immunofluorescence. J Clin Pathol 1976; 29: 403-10.
11. Toh B-H. Smooth muscle autoantibodies and autoantigens. Clin Exp Immunol 1979; 38: 621-8.
12. Kurki P, Mietinnen A, Linder E et al. Different types of smooth muscle antibodies in chronic active hepatitis and primary biliary cirrhosis: their diagnostic and prognostic significance. Gut 1980; 21: 878-84.
13. Vergani D, Alvarez F, Bianchi FB et al. Liver autoimmune serology: A consensus statement from the Committee for Autoimmune Serology of the International Autoimmune Hepatitis Group. J Hepatol 2004; 41: 677-83.
14. Silvestrini RA, Benson EM. Whither smooth muscle antibodies in the new millennium. J Clin Pathol 2001; 54: 677-8.
15. Granito A, Moratori L, Pappas G et al. Antibodies to filamentous actin (F-actin) in type 1 autoimmune hepatitis. J Clin Pathol 2006; 59: 280-4.
16. Mackay IR, Martinez-Neira R, Whittingham S et al. Autoantigenecity of actin. In: Dos Remedios CG, Chhabra D, eds. Actin, Actin-binding Proteins and Disease. New York: Springer, 2007; 50-64.
17. dos Remedios CG, Chhabra D, Kekic M et al. Actin binding proteins: regulation of cytoskeletal microfilaments. Physiol Rev 2003; 83: 433-72.
18. Mackay IR. The etiopathogenesis of autoimmune disease. Semin Liver Dis 2005; 25: 239-50.
19. Longhi MS, Ma Y, Bogdanos DP et al. Immunodominant HLA A2 restricted CD8 T-cell epitope in autoimmune hepatitis type 2. Hepatology 2004; 40 (Suppl 1): 422A.
20. Yokasawa S, Yoshizawa K, Ota M et al. A genomewide DNA microsatellite association study of Japanese patients with autoimmune hepatitis type 1. Hepatology 2007; 45: 384-90.
21. Jiang J, Chess L. Regulation of immune responses by T cells. N Engl J Med 2004; 354: 1166-76.
22. Ahrens EJ, Payne M, Kunkel H et al. Primary biliary cirrhosis. Medicine 1950; 29: 299-364.
23. Ishibashi H, Shimoda S, Gershwim ME. The immune response to mitochondrial autoantigens. Semin Liver Dis 2005; 25: 337-46.
24. Shimoda S, Van de Water J, Ansari A et al. Identification and precursor frequency analysis of a common T cell epitope motif in mitochondrial autoantigens in primary biliary cirrhosis. J Clin Invest 1998; 102: 1831-40.
25. Mackay IR, Whittingham SF, Fida S et al. The perculiar autoimmunity of primary biliary cirrhosis. Immunol Rev 2000; 174: 226-37.
26. Kita H, Matsumura S, He X-S et al. Quantitative and functional analysis of PDC-E2-specific autoreactive cytotoxic T lymphocytes in primary biliary cirrhosis. J Clin Invest 2002; 109: 1231-40.
27. Rieger R, Leung PSC, Jeddeloh MR et al. Identification of 2-nonynoic acid, a cosmetic component, as a potential trigger of primary biliary cirrhosis. J Autoimmun 2006; 27: 7-16.
28. Casiola-Rosen L, Rosen A. Apoptotic cells as a source of autoantigen. In: Rose NR, Mackay IR, eds. The Autoimmune Diseases, 4th edn. London: Elsevier, 2006; 193-201.
29. Leung PSC, Coppel RL, Gershwin ME. Etiology of primary biliary cirrhosis. The search for the culprit. Semin Liver Dis 2005; 25: 327-36.
30. Zamanou A, Samiotaki M, Panayotou G et al. Fine specificity and subclasses of IgG anti-actin autoantibodies differ in health and disease. J Autoimmun 2003; 20: 333-44.
31. Beaune P, Dansette PM, Mansuy D et al. Human anti-endoplasmic reticulum autoantibodies appearing in a drug-induced hepatitis directed against a human liver cytochrome P450 that hydroxylates the drug. Proc Natl Acad Sci USA 1987; 84: 551-5.